Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: A multicenter experience
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 60 (5) , 103242
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Extracorporeal photopheresis in the management of graft-versus-host diseaseCurrent Oncology, 2014
- Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic formBritish Journal of Dermatology, 2013
- Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: Results of treatment with the COBE Spectra SystemBone Marrow Transplantation, 2012
- Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHDBone Marrow Transplantation, 2011
- Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cellsBlood, 2008
- Extracorporeal photopheresis for the treatment of steroid refractory acute GVHDBone Marrow Transplantation, 2008
- Extracorporeal photophoresis increases sensitivity of monocytes from patients with graft‐versus‐host disease to HLA‐DR–mediated cell deathTransfusion, 2007
- Technology Insight: ECP for the treatment of GvHD—can we offer selective immune control without generalized immunosuppression?Nature Clinical Practice Oncology, 2006
- Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host diseaseBlood, 2002
- IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADEBritish Journal of Haematology, 1997